Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.
Morepen Laboratories Limited (MOREPENLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The MOREPENLAB share price is ₹99.15 (+7.48% today), with a market capitalisation of ₹54B and a price-to-earnings (P/E) ratio of 28.9. MarketRipple tracks the MOREPENLAB investment thesis, the ripple-chain impact of market events on Morepen Laboratories Limited, and the Healthcare sector outlook.
Open
₹93.50
High
₹99.15
Low
₹93.50
Prev. Close
₹92.25
52W High
₹150.70
52W Low
₹33.05
Day range
₹93.50–₹99.15
52-week range
₹33.05–₹150.70
Volume
7.0M
P/E
28.9
ROE
14.6%
D/E
0.17
Margin
8.2%
Morepen Laboratories Limited (NSE: MOREPENLAB) is currently trading at ₹99.15 (+7.48%).
Morepen Laboratories Limited's market capitalization is ₹54B.
Morepen Laboratories Limited's price-to-earnings (P/E) ratio is 28.9.
Morepen Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).